Heijtink RA - Search Results

1

Quantitative measurement of HBeAg in chronic hepatitis B: a comparison between a radioimmunoassay, a fluorescence ELISA and a chemiluminescence ELISA.

Heijtink RA, Snobl J, Kruining J, Kerkhof-Los C, de Man RA, Janssen HL, Schalm SW. Heijtink RA, et al. J Med Virol. 1995 Nov;47(3):245-50. doi: 10.1002/jmv.1890470310. J Med Virol. 1995. PMID: 8551276

2

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

Janssen HL, Berk L, Schalm SW, Heijtink RA, Hess G, Rossol S, Meyer zum Buschenfelde KH, Chamuleau RA, Jansen PL, Reesink HW, et al. Janssen HL, et al. Among authors: heijtink ra. Gut. 1992 Aug;33(8):1094-8. doi: 10.1136/gut.33.8.1094. Gut. 1992. PMID: 1398234 Free PMC article.

3

[Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].

Janssen HL, Berk L, de Man RA, Heijtink RA, Schalm SW. Janssen HL, et al. Among authors: heijtink ra. Ned Tijdschr Geneeskd. 1992 Apr 25;136(17):835-9. Ned Tijdschr Geneeskd. 1992. PMID: 1522928 Dutch.

4

Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes.

Heijtink RA, Knol RM, Schalm SW. Heijtink RA, et al. J Med Virol. 1989 Feb;27(2):151-4. doi: 10.1002/jmv.1890270216. J Med Virol. 1989. PMID: 2522147 Clinical Trial.

5

Long-term immune reactivity to pre-S(2)-antigen after acute hepatitis B infection.

Heijtink RA, de Wilde GA, van Hattum J, Schalm SW. Heijtink RA, et al. J Med Virol. 1989 Feb;27(2):95-9. doi: 10.1002/jmv.1890270205. J Med Virol. 1989. PMID: 2646395

6

Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapy.

Heijtink RA, Smal P, ten Kate FJ, Kruining J, Schalm SW. Heijtink RA, et al. Antiviral Res. 1987 Jul;7(6):329-40. doi: 10.1016/0166-3542(87)90015-5. Antiviral Res. 1987. PMID: 3674854

7

Quantitative relationship between HBeAg and DNA polymerase activity in sera from patients with chronic active hepatitis during a three-month period.

Heijtink RA, van der Waart M, Weimar W, Schalm SW, Masurel N. Heijtink RA, et al. J Med Virol. 1980;5(4):295-302. doi: 10.1002/1096-9071(1980)5:4<295::aid-jmv1890050405>3.0.co;2-5. J Med Virol. 1980. PMID: 7229620

8

Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy.

Janssen HL, Kerhof-Los CJ, Heijtink RA, Schalm SW. Janssen HL, et al. Among authors: heijtink ra. Antiviral Res. 1994 Apr;23(3-4):251-7. doi: 10.1016/0166-3542(94)90022-1. Antiviral Res. 1994. PMID: 8042863

9

Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays.

Janssen HL, Schoenmaker-Weber YA, Kruining H, Schalm SW, Heijtink RA. Janssen HL, et al. Among authors: heijtink ra. J Med Virol. 1993 Aug;40(4):307-12. doi: 10.1002/jmv.1890400408. J Med Virol. 1993. PMID: 8228921

10

Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes.

del Canho R, Grosheide PM, Voogd M, Huisman WM, Heijtink RA, Schalm SW. del Canho R, et al. Among authors: heijtink ra. J Med Virol. 1993 Sep;41(1):30-4. doi: 10.1002/jmv.1890410107. J Med Virol. 1993. PMID: 8228934 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters